Skip to main content
. 2014 Jun 8;46(9):1833–1841. doi: 10.1007/s11255-014-0731-0

Table 1.

Characteristics of Japanese HD patients by allopurinol use

Patient characteristics (mean ± SD or  %) All patients (N = 6,252) With allopurinol use (N = 1,561) No allopurinol use (N = 4,691) p value*
Uric acid (mg/dL) 7.7 ± 1.5 7.0 ± 1.5 8.0 ± 1.4 <0.001
Uric acid >9 mg/dL 17 % 8 % 20 % <0.001
Demographics
Age (years) 60.8 ± 12.8 59.7 ± 12.2 61.2 ± 13.0 <0.001
Male (%) 61 % 68 % 59 % <0.001
Duration on dialysis (months) 77.1 ± 81.0 79.5 ± 79.3 76.3 ± 81.5 0.09
Dry weight (kg) 52.8 ± 10.6 54.9 ± 11.1 52.1 ± 10.3 <0.001
Laboratory data
Serum albumin (g/dL) 3.77 ± 0.44 3.79 ± 0.41 3.77 ± 0.45 <0.001
Serum creatinine (mg/dL) 10.7 ± 3.0 11.3 ± 3.2 10.5 ± 3.0 <0.001
nPCR 1.03 ± 0.23 1.08 ± 0.24 1.02 ± 0.23 <0.001
Cachectic (%) 5 % 3 % 5 % 0.001
WBC count (1,000 per mm3) 6.0 ± 2.0 6.1 ± 2.0 6.0 ± 2.0 0.04
Hemoglobin (g/dL) 9.9 ± 1.4 10.0 ± 1.4 9.9 ± 1.4 0.002
Serum calciumalb (mg/dL) 9.3 ± 0.9 9.4 ± 0.9 9.2 ± 1.0 <0.001
Serum phosphorus (mg/dL) 5.6 ± 1.6 5.8 ± 1.6 5.6 ± 1.6 <0.001
Single pool (Kt/V) 1.31 ± 0.30 1.30 ± 0.29 1.31 ± 0.30 0.7
Comorbid conditions
Coronary artery disease 28 % 26 % 28 % 0.01
Other cardiovascular disease 28 % 28 % 28 % 0.6
Cerebrovascular disease 14 % 14 % 14 % 0.2
Congestive heart failure 18 % 16 % 18 % 0.04
Diabetes mellitus 31 % 25 % 33 % <0.001
GI bleeding 4 % 4 % 4 % 0.5
Hypertension 67 % 67 % 67 % 0.2
Lung disease 2 % 2 % 2 % 0.5
Neurological disease 7 % 4 % 7 % <0.001
Psychiatric disorder 3 % 3 % 3 % 0.2
Peripheral vascular disease 13 % 11 % 14 % <0.001
Recurrent cellulitis 3 % 2 % 3 % 0.01

p value represents association of allopurinol with each patient characteristic, adjusted for DOPPS phase and accounting for facility clustering effects. Linear mixed models for continuous variables and generalized estimating equations (GEE) models with logit link function for binary variables were used